|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,794.00 JPY | -2.00% |
|
-5.47% | -5.45% |
| 05-11 | Jefferies Adjusts Chugai Pharmaceutical's Price Target to 8,500 Yen from 9,100 Yen, Keeps at Hold | MT |
| 05-06 | Japan's Nikkei blazes past 63,000 on earnings, Iran peace optimism; JGBs rally | RE |
| Capitalization | 12,827B 81.37B 69.34B 63.55B 60.13B 111B 7,781B 112B 750B 294B 3,698B 305B 299B | P/E ratio 2026 * |
25.1x | P/E ratio 2027 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 11,857B 75.22B 64.1B 58.74B 55.58B 103B 7,192B 104B 693B 272B 3,418B 282B 276B | EV / Sales 2026 * |
8.58x | EV / Sales 2027 * | 7.63x |
| Free-Float |
38.12% | Yield 2026 * |
1.75% | Yield 2027 * | 1.98% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -2.00% | ||
| 1 week | -5.47% | ||
| Current month | -3.97% | ||
| 1 month | -10.16% | ||
| 3 months | -13.61% | ||
| 6 months | +3.63% | ||
| Current year | -5.45% |
| 1 week | 7,727 | 8,248 | |
| 1 month | 7,402 | 9,013 | |
| Current year | 7,402 | 10,700 | |
| 1 year | 5,942 | 10,700 | |
| 3 years | 3,580 | 10,700 | |
| 5 years | 3,191 | 10,700 | |
| 10 years | 1,003.33 | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 81 | 2015-02-28 |
Motoo Ueno
BRD | Director/Board Member | 68 | 1993-02-28 |
James H. Sabry
BRD | Director/Board Member | 67 | 2019-02-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.00% | -5.47% | -5.17% | +120.67% | 83.36B | ||
| +2.37% | +2.27% | +34.76% | +127.27% | 862B | ||
| +1.28% | +0.03% | +45.42% | +39.30% | 533B | ||
| +2.51% | -0.14% | +12.60% | +41.80% | 358B | ||
| -0.94% | -0.38% | +22.40% | +11.63% | 328B | ||
| +1.82% | +1.75% | +34.26% | +15.30% | 286B | ||
| +1.93% | +1.81% | +27.49% | +25.19% | 279B | ||
| +0.98% | -0.65% | +47.91% | -4.41% | 275B | ||
| -1.17% | +4.79% | -33.27% | -48.68% | 210B | ||
| +2.03% | +3.84% | +26.49% | +44.77% | 178B | ||
| Average | +0.19% | -0.32% | +21.29% | +37.28% | 339.22B | |
| Weighted average by Cap. | +0.24% | -0.51% | +27.70% | +49.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,382B 8.77B 7.47B 6.85B 6.48B 12.01B 838B 12.11B 80.82B 31.71B 398B 32.92B 32.21B | 1,521B 9.65B 8.22B 7.54B 7.13B 13.22B 923B 13.33B 88.95B 34.9B 439B 36.23B 35.45B |
| Net income | 511B 3.24B 2.76B 2.53B 2.39B 4.44B 310B 4.47B 29.85B 11.71B 147B 12.16B 11.9B | 589B 3.74B 3.18B 2.92B 2.76B 5.12B 357B 5.16B 34.43B 13.51B 170B 14.02B 13.72B |
| Net Debt | -970B -6.16B -5.25B -4.81B -4.55B -8.43B -589B -8.5B -56.73B -22.26B -280B -23.11B -22.61B | -1,226B -7.78B -6.63B -6.07B -5.75B -10.65B -744B -10.75B -71.7B -28.13B -353B -29.2B -28.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-12 | 7,794.00 ¥ | -2.00% | 2,123,700 |
| 26-05-11 | 7,953.00 ¥ | +0.67% | 3,038,800 |
| 26-05-08 | 7,900.00 ¥ | -2.41% | 4,228,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















